Eisai Switches Proton Pump Inhibitor Rabeprazole To OTC In Japan

 
• By David Ridley

Eisai aims to support people in Japan with severe heartburn and discomfort caused by gastric acid related conditions by switching from prescription to OTC status its Pariet-branded proton pump inhibitor.

Tokyo-based firm Eisai has switched its Pariet PPI to OTC in Japan

More from Rx-to-OTC Switch

More from Geography